MBIO News and Press, Mustang Bio Inc. From 06/06/21

Penny Stocks To Watch For June Trading penny stocks is something that millions of people do daily. But it’s isn’t something that everyone has been able to master. Best-known for their high-flying moves in price, the “land of cheap stocks” is more frequently c...

Today, we revisit Mustang Bio for the first time since early in 2021. The company's pipeline has multiple 'shots on goal' and recently has seen some milestones achieved as well as some positive analyst commentary. A full investment analysis follows in the paragraphs below. F...

Shares of Mustang Bio (NASDAQ: MBIO) were galloping 13.3% higher as of 3:43 p.m. EDT on Tuesday. The big gain came on the heels of two developments. Mustang Bio and cancer research and treatment center City of Hope announced the first patient dosing in an early-stage clinical study ...

“We are bullish on the cell and gene therapy space,” noted BTIG analyst Justin Zelin highlighting the importance of stock picking in the area given “the limited targets and indications to market.”In the area of cell therapy, Zelin initiates the coverage on six comp...

Are Analysts Right About These Penny Stocks? Penny stocks are well-known for their volatile nature. The definition of these cheap shares refers to those trading under $5. So even a 50 cent move can be a meaningful gain or loss. For this reason, traders have flocked in droves to find the...

The first patient has been dosed in Mustang Bio's (MBIO) Phase 1 trial to establish the safety and feasibility of administering MB-101 (autologous IL13Rα2-CAR T cells) to patients with leptomeningeal brain tumors.The trial will enroll up to 30 patients. All subjects will...

Stealth BioTherapeutics (MITO) +31% on Q1 results.Ultralife Corporation (ULBI) +22% on new contract from U.S. Army.China HGS Real Estate Inc. (HGSH) +14% on Q2 results.XpresSpa Group (XSPA) +9% on Q1 results.Reliance Global Group (RELI) +8%.Express (EXPR) +7%.Eloxx Pharmac...

WORCESTER, Mass. and DUARTE, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hemato...

Mustang Bio (MBIO): Q1 GAAP EPS of -$0.19 in-line.As of March 31, 2021, Mustang’s cash and cash equivalents and restricted cash totaled $130.4 million, compared to $98.8 million as of December 31, 2020, an increase of $31.6 million year-to-date.Press release. For further details see:...

WORCESTER, Mass., May 14, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, soli...